{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:51:55Z","timestamp":1791341515967,"version":"4.3.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T00:00:00Z","timestamp":1620691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000185","name":"United States Department of Defense | Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["HR0011-17-2-0036"],"award-info":[{"award-number":["HR0011-17-2-0036"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["219588\/Z\/19\/Z"],"award-info":[{"award-number":["219588\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Dengue virus (DENV) is spread from human to human through the bite of the female <jats:italic>Aedes aegypti<\/jats:italic> mosquito and leads to about 100 million clinical infections yearly. Treatment options and vaccine availability for DENV are limited. Defective interfering particles (DIPs) are considered a promising antiviral approach but infectious virus contamination has limited their development. Here, a DENV-derived DIP production cell line was developed that continuously produced DENV-free DIPs. The DIPs contained and could deliver to cells a DENV serotype 2 subgenomic defective-interfering RNA, which was originally discovered in DENV infected patients. The DIPs released into cell culture supernatant were purified and could potently inhibit replication of all DENV serotypes in cells. Antiviral therapeutics are limited for many viral infection. The DIP system described could be re-purposed to make antiviral DIPs for many other RNA viruses such as SARS-CoV-2, yellow fever, West Nile and Zika viruses.<\/jats:p>","DOI":"10.1038\/s42003-021-02064-7","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T10:09:20Z","timestamp":1620727760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Dengue virus-free defective interfering particles have potent and broad anti-dengue virus activity"],"prefix":"10.1038","volume":"4","author":[{"given":"Dongsheng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hsuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7248-0101","authenticated-orcid":false,"given":"Daniel J.","family":"Rawle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonglan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mazhar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Aaskov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3690-0150","authenticated-orcid":false,"given":"David","family":"Harrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"2064_CR1","doi-asserted-by":"crossref","unstructured":"Deng S. Q. et al. A review on dengue vaccine development. Vaccines 8, 63 (2020).","DOI":"10.3390\/vaccines8010063"},{"key":"2064_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1126\/science.98.2534.87.b","volume":"98","author":"W Henle","year":"1943","unstructured":"Henle, W. & Henle, G. Interference of inactive virus with the propagation of virus of influenza. Science 98, 87\u201389 (1943).","journal-title":"Science"},{"key":"2064_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/srep36317","volume":"6","author":"E Petterson","year":"2016","unstructured":"Petterson, E., Guo, T. C., Evensen, O. & Mikalsen, A. B. Experimental piscine alphavirus RNA recombination in vivo yields both viable virus and defective viral RNA. Sci. Rep. 6, 36317 (2016).","journal-title":"Sci. Rep."},{"key":"2064_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1128\/jvi.30.1.38-44.1979","volume":"30","author":"KB Logan","year":"1979","unstructured":"Logan, K. B. Generation of defective interfering particles of Semliki Forest virus in a clone of Aedes albopictus (mosquito) cells. J. Virol. 30, 38\u201344 (1979).","journal-title":"J. Virol."},{"key":"2064_CR5","doi-asserted-by":"publisher","first-page":"6720","DOI":"10.1128\/JVI.77.12.6720-6730.2003","volume":"77","author":"S Raman","year":"2003","unstructured":"Raman, S., Bouma, P., Williams, G. D. & Brian, D. A. Stem-loop III in the 5\u2019 untranslated region is a cis-acting element in bovine coronavirus defective interfering RNA replication. J. Virol. 77, 6720\u20136730 (2003).","journal-title":"J. Virol."},{"key":"2064_CR6","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/978-1-4684-5823-7_46","volume":"276","author":"S Makino","year":"1990","unstructured":"Makino, S. & Lai, M. M. Studies of coronavirus DI RNA replication using in vitro constructed DI cDNA clones. Adv. Exp. Med. Biol. 276, 341\u2013347 (1990).","journal-title":"Adv. Exp. Med. Biol."},{"key":"2064_CR7","doi-asserted-by":"publisher","first-page":"6045","DOI":"10.1128\/jvi.64.12.6045-6053.1990","volume":"64","author":"S Makino","year":"1990","unstructured":"Makino, S., Yokomori, K. & Lai, M. M. Analysis of efficiently packaged defective interfering RNAs of murine coronavirus: localization of a possible RNA-packaging signal. J. Virol. 64, 6045\u20136053 (1990).","journal-title":"J. Virol."},{"key":"2064_CR8","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1126\/science.1115030","volume":"311","author":"J Aaskov","year":"2006","unstructured":"Aaskov, J., Buzacott, K., Thu, H. M., Lowry, K. & Holmes, E. C. Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes. Science 311, 236\u2013238 (2006).","journal-title":"Science"},{"key":"2064_CR9","doi-asserted-by":"publisher","first-page":"e19447","DOI":"10.1371\/journal.pone.0019447","volume":"6","author":"D Li","year":"2011","unstructured":"Li, D. et al. Defective interfering viral particles in acute dengue infections. PLoS One 6, e19447 (2011).","journal-title":"PLoS One"},{"key":"2064_CR10","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.virol.2014.08.013","volume":"468-470","author":"D Li","year":"2014","unstructured":"Li, D. & Aaskov, J. Sub-genomic RNA of defective interfering (D.I.) dengue viral particles is replicated in the same manner as full length genomes. Virology 468-470, 248\u2013255 (2014).","journal-title":"Virology"},{"key":"2064_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/0042-6822(77)90407-X","volume":"77","author":"M Popescu","year":"1977","unstructured":"Popescu, M. & Lehmann-Grube, F. Defective interfering particles in mice infected with lymphocytic choriomeningitis virus. Virology 77, 78\u201383 (1977).","journal-title":"Virology"},{"key":"2064_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0042-6822(82)90405-6","volume":"116","author":"MA Brinton","year":"1982","unstructured":"Brinton, M. A. Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse cells. I. Generation of defective nonplaquing virus particles. Virology 116, 84\u201398 (1982).","journal-title":"Virology"},{"key":"2064_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/978-3-642-71272-2_2","volume":"128","author":"AD Barrett","year":"1986","unstructured":"Barrett, A. D. & Dimmock, N. J. Defective interfering viruses and infections of animals. Curr. Top. Microbiol. Immunol. 128, 55\u201384 (1986).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"2064_CR14","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1128\/JVI.02674-08","volume":"83","author":"K Sugiyama","year":"2009","unstructured":"Sugiyama, K. et al. Genetic analysis of hepatitis C virus with defective genome and its infectivity in vitro. J. Virol. 83, 6922\u20136928 (2009).","journal-title":"J. Virol."},{"key":"2064_CR15","doi-asserted-by":"publisher","first-page":"8064","DOI":"10.1128\/JVI.00240-13","volume":"87","author":"K Saira","year":"2013","unstructured":"Saira, K. et al. Sequence analysis of in vivo defective interfering-like RNA of influenza A H1N1 pandemic virus. J. Virol. 87, 8064\u20138074 (2013).","journal-title":"J. Virol."},{"key":"2064_CR16","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/226325a0","volume":"226","author":"AS Huang","year":"1970","unstructured":"Huang, A. S. & Baltimore, D. Defective viral particles and viral disease processes. Nature 226, 325\u2013327 (1970).","journal-title":"Nature"},{"key":"2064_CR17","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1128\/JVI.02190-15","volume":"90","author":"F Akpinar","year":"2016","unstructured":"Akpinar, F., Timm, A. & Yin, J. High-throughput single-cell kinetics of virus infections in the presence of defective interfering particles. J. Virol. 90, 1599\u20131612 (2016).","journal-title":"J. Virol."},{"key":"2064_CR18","first-page":"129","volume":"37","author":"CA Mims","year":"1956","unstructured":"Mims, C. A. Rift Valley Fever virus in mice. IV. Incomplete virus; its production and properties. Br. J. Exp. Pathol. 37, 129\u2013143 (1956).","journal-title":"Br. J. Exp. Pathol."},{"key":"2064_CR19","doi-asserted-by":"publisher","first-page":"2105","DOI":"10.1073\/pnas.70.7.2105","volume":"70","author":"M Doyle","year":"1973","unstructured":"Doyle, M. & Holland, J. J. Prophylaxis and immunization in mice by use of virus-free defective T particles to protect against intracerebral infection by vesicular stomatitis virus. Proc. Natl Acad. Sci. USA 70, 2105\u20132108 (1973).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2064_CR20","doi-asserted-by":"publisher","first-page":"e1006365","DOI":"10.1371\/journal.ppat.1006365","volume":"13","author":"E Jaworski","year":"2017","unstructured":"Jaworski, E. & Routh, A. Parallel ClickSeq and Nanopore sequencing elucidates the rapid evolution of defective-interfering RNAs in Flock House virus. PLoS Pathog. 13, e1006365 (2017).","journal-title":"PLoS Pathog."},{"key":"2064_CR21","doi-asserted-by":"publisher","first-page":"e0212757","DOI":"10.1371\/journal.pone.0212757","volume":"14","author":"N Bdeir","year":"2019","unstructured":"Bdeir, N. et al. A system for production of defective interfering particles in the absence of infectious influenza A virus. PLoS One 14, e0212757 (2019).","journal-title":"PLoS One"},{"key":"2064_CR22","doi-asserted-by":"publisher","first-page":"5217","DOI":"10.1128\/JVI.03193-13","volume":"88","author":"NJ Dimmock","year":"2014","unstructured":"Dimmock, N. J. & Easton, A. J. Defective interfering influenza virus RNAs: time to reevaluate their clinical potential as broad-spectrum antivirals? J. Virol. 88, 5217\u20135227 (2014).","journal-title":"J. Virol."},{"key":"2064_CR23","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1432-1033.1997.00741.x","volume":"247","author":"MD Been","year":"1997","unstructured":"Been, M. D. & Wickham, G. S. Self-cleaving ribozymes of hepatitis delta virus RNA. Eur. J. Biochem. 247, 741\u2013753 (1997).","journal-title":"Eur. J. Biochem."},{"key":"2064_CR24","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.virusres.2013.12.001","volume":"180","author":"JA Usme-Ciro","year":"2014","unstructured":"Usme-Ciro, J. A., Lopera, J. A., Enjuanes, L., Almazan, F. & Gallego-Gomez, J. C. Development of a novel DNA-launched dengue virus type 2 infectious clone assembled in a bacterial artificial chromosome. Virus Res. 180, 12\u201322 (2014).","journal-title":"Virus Res."},{"key":"2064_CR25","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1099\/0022-1317-70-6-1409","volume":"70","author":"M Tadano","year":"1989","unstructured":"Tadano, M., Makino, Y., Fukunaga, T., Okuno, Y. & Fukai, K. Detection of dengue 4 virus core protein in the nucleus. I. A monoclonal antibody to dengue 4 virus reacts with the antigen in the nucleus and cytoplasm. J. Gen. Virol. 70, 1409\u20131415 (1989).","journal-title":"J. Gen. Virol."},{"key":"2064_CR26","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1099\/0022-1317-73-11-2999","volume":"73","author":"R Bulich","year":"1992","unstructured":"Bulich, R. & Aaskov, J. G. Nuclear localization of dengue 2 virus core protein detected with monoclonal antibodies. J. Gen. Virol. 73, 2999\u20133003 (1992).","journal-title":"J. Gen. Virol."},{"key":"2064_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0065-3527(03)59004-2","volume":"59","author":"EG Westaway","year":"2003","unstructured":"Westaway, E. G., Mackenzie, J. M. & Khromykh, A. A. Kunjin RNA replication and applications of Kunjin replicons. Adv. Virus Res. 59, 99\u2013140 (2003).","journal-title":"Adv. Virus Res."},{"key":"2064_CR28","doi-asserted-by":"publisher","first-page":"4640","DOI":"10.3390\/v7082837","volume":"7","author":"VJ Klema","year":"2015","unstructured":"Klema, V. J., Padmanabhan, R. & Choi, K. H. Flaviviral replication complex: coordination between RNA synthesis and 5\u2019-RNA capping. Viruses 7, 4640\u20134656 (2015).","journal-title":"Viruses"},{"key":"2064_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654\u2013659 (2007).","journal-title":"Nat. Cell Biol."},{"key":"2064_CR30","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1002\/jcb.26077","volume":"118","author":"Y Zhou","year":"2017","unstructured":"Zhou, Y. et al. Exosomes transfer among different species cells and mediating miRNAs delivery. J. Cell Biochem. 118, 4267\u20134274 (2017).","journal-title":"J. Cell Biochem."},{"key":"2064_CR31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4236\/wjv.2012.23020","volume":"2","author":"Y Kurosawa","year":"2012","unstructured":"Kurosawa, Y., Saito, M., Kobayashi, S. & Okuyama, T. Purification of dengue virus particles by one-step ceramic hydroxyapatite chromatography. World J. Vaccines 2, 155\u2013160 (2012).","journal-title":"World J. Vaccines"},{"key":"2064_CR32","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1128\/AEM.02773-15","volume":"82","author":"SE Beck","year":"2015","unstructured":"Beck, S. E. et al. Comparison of UV-Induced Inactivation and RNA Damage in MS2 Phage across the Germicidal UV Spectrum. Appl Environ. Microbiol. 82, 1468\u20131474 (2015).","journal-title":"Appl Environ. Microbiol."},{"key":"2064_CR33","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00253-017-8660-3","volume":"102","author":"MA Wasik","year":"2018","unstructured":"Wasik, M. A., Eichwald, L., Genzel, Y. & Reichl, U. Cell culture-based production of defective interfering particles for influenza antiviral therapy. Appl. Microbiol. Biotechnol. 102, 1167\u20131177 (2018).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"2064_CR34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/infdis\/136.3.391","volume":"136","author":"RM Welsh","year":"1977","unstructured":"Welsh, R. M., Lampert, P. W. & Oldstone, M. B. Prevention of virus-induced cerebellar diseases by defective-interfering lymphocytic choriomeningitis virus. J. Infect. Dis. 136, 391\u2013399 (1977).","journal-title":"J. Infect. Dis."},{"key":"2064_CR35","doi-asserted-by":"crossref","unstructured":"Welch S. R. et al. Inhibition of Nipah virus by defective interfering particles. J. Infect. Dis.\u00a0221, S460\u2013S470 (2020).","DOI":"10.1093\/infdis\/jiz564"},{"key":"2064_CR36","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1146\/annurev.mi.27.100173.000533","volume":"27","author":"AS Huang","year":"1973","unstructured":"Huang, A. S. Defective interfering viruses. Annu. Rev. Microbiol. 27, 101\u2013117 (1973).","journal-title":"Annu. Rev. Microbiol."},{"key":"2064_CR37","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF01242026","volume":"4","author":"S Gard","year":"1952","unstructured":"Gard, S., Von Magnus, P., Svedmyr, A. & Birch-Andersen, A. Studies on the sedimentation of influenza virus. Arch. Gesamt. Virusforsch. 4, 591\u2013611 (1952).","journal-title":"Arch. Gesamt. Virusforsch."},{"key":"2064_CR38","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41564-019-0465-y","volume":"4","author":"M Vignuzzi","year":"2019","unstructured":"Vignuzzi, M. & Lopez, C. B. Defective viral genomes are key drivers of the virus-host interaction. Nat. Microbiol. 4, 1075\u20131087 (2019).","journal-title":"Nat. Microbiol."},{"key":"2064_CR39","doi-asserted-by":"publisher","first-page":"e1005122","DOI":"10.1371\/journal.ppat.1005122","volume":"11","author":"Y Sun","year":"2015","unstructured":"Sun, Y. et al. Immunostimulatory defective viral genomes from respiratory syncytial virus promote a strong innate antiviral response during infection in mice and humans. PLoS Pathog. 11, e1005122 (2015).","journal-title":"PLoS Pathog."},{"key":"2064_CR40","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3389\/fmicb.2019.01852","volume":"10","author":"Y Yang","year":"2019","unstructured":"Yang, Y. et al. The antiviral and antitumor effects of defective interfering particles\/genomes and their mechanisms. Front. Microbiol. 10, 1852 (2019).","journal-title":"Front. Microbiol."},{"key":"2064_CR41","doi-asserted-by":"publisher","first-page":"6719","DOI":"10.1128\/JVI.75.14.6719-6728.2001","volume":"75","author":"AA Khromykh","year":"2001","unstructured":"Khromykh, A. A., Meka, H., Guyatt, K. J. & Westaway, E. G. Essential role of cyclization sequences in flavivirus RNA replication. J. Virol. 75, 6719\u20136728 (2001).","journal-title":"J. Virol."},{"key":"2064_CR42","doi-asserted-by":"crossref","unstructured":"Liu Z. Y. et al. Viral RNA switch mediates the dynamic control of flavivirus replicase recruitment by genome cyclization. Elife 5, e17636 (2016).","DOI":"10.7554\/eLife.17636"},{"key":"2064_CR43","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1093\/nar\/gkz686","volume":"47","author":"TJ Sanford","year":"2019","unstructured":"Sanford, T. J., Mears, H. V., Fajardo, T., Locker, N. & Sweeney, T. R. Circularization of flavivirus genomic RNA inhibits de novo translation initiation. Nucleic Acids Res. 47, 9789\u20139802 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2064_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1021\/acsinfecdis.9b00384","volume":"6","author":"S Wang","year":"2020","unstructured":"Wang, S. et al. Subgenomic RNA from dengue virus type 2 suppresses replication of dengue virus genomes and interacts with virus-encoded NS3 and NS5 proteins. ACS Infect. Dis. 6, 436\u2013446 (2020).","journal-title":"ACS Infect. Dis."},{"key":"2064_CR45","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1128\/JVI.75.10.4633-4640.2001","volume":"75","author":"AA Khromykh","year":"2001","unstructured":"Khromykh, A. A., Varnavski, A. N., Sedlak, P. L. & Westaway, E. G. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J. Virol. 75, 4633\u20134640 (2001).","journal-title":"J. Virol."},{"key":"2064_CR46","doi-asserted-by":"crossref","unstructured":"Comas-Garcia M. Packaging of genomic RNA in positive-sense single-stranded RNA viruses: a complex story. Viruses 11, (2019).","DOI":"10.3390\/v11030253"},{"key":"2064_CR47","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1099\/vir.0.034132-0","volume":"92","author":"PD Scott","year":"2011","unstructured":"Scott, P. D., Meng, B., Marriott, A. C., Easton, A. J. & Dimmock, N. J. Defective interfering influenza A virus protects in vivo against disease caused by a heterologous influenza B virus. J. Gen. Virol. 92, 2122\u20132132 (2011).","journal-title":"J. Gen. Virol."},{"key":"2064_CR48","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1016\/j.vaccine.2011.01.102","volume":"29","author":"AJ Easton","year":"2011","unstructured":"Easton, A. J. et al. A novel broad-spectrum treatment for respiratory virus infections: influenza-based defective interfering virus provides protection against pneumovirus infection in vivo. Vaccine 29, 2777\u20132784 (2011).","journal-title":"Vaccine"},{"key":"2064_CR49","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"2064_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2019.02.002","volume":"36","author":"SR Morrone","year":"2019","unstructured":"Morrone, S. R. & Lok, S. M. Structural perspectives of antibody-dependent enhancement of infection of dengue virus. Curr. Opin. Virol. 36, 1\u20138 (2019).","journal-title":"Curr. Opin. Virol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02064-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02064-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T10:19:28Z","timestamp":1675246768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-021-02064-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2064"],"URL":"https:\/\/doi.org\/10.1038\/s42003-021-02064-7","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,11]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"557"}}